Tissue Inhibitor of Metalloproteinase-1 Alters the Tumorigenicity of Burkitt’s Lymphoma via Divergent Effects on Tumor Growth and Angiogenesis
- 1 April 2001
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 158 (4) , 1207-1215
- https://doi.org/10.1016/s0002-9440(10)64070-9
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Epstein–Barr Virus InfectionNew England Journal of Medicine, 2000
- The Hallmarks of CancerCell, 2000
- Multiple functions of tissue inhibitors of metalloproteinases (TIMPs): new aspects in hematopoiesisPlatelets, 1999
- Tyrosine phosphorylation is crucial for growth signaling by tissue inhibitors of metalloproteinases (TIMP‐1 and TIMP‐2)FEBS Letters, 1996
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell LymphomasThe American Journal of Surgical Pathology, 1996
- The Role of Metalloproteinases and Their Inhibitors in Hematological DisordersCritical Reviews™ in Oncogenesis, 1996
- Regression of Experimental Human Leukemias and Solid Tumors Induced by Epstein-Barr Virus-Immortalized B CellsLeukemia & Lymphoma, 1995
- Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2)Biochemical and Biophysical Research Communications, 1990
- The Pathogenesis of Burkitt's LymphomaPublished by Elsevier ,1990